Lapeyre-Mestre, M. (2019). Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies. EClinicalMedicine.
Citação norma ChicagoLapeyre-Mestre, Maryse. "Considering Sex-specific Adverse Drug Reactions Should Be a Priority in Pharmacovigilance and Pharmacoepidemiological Studies." EClinicalMedicine 2019.
MLA citiranjeLapeyre-Mestre, Maryse. "Considering Sex-specific Adverse Drug Reactions Should Be a Priority in Pharmacovigilance and Pharmacoepidemiological Studies." EClinicalMedicine 2019.
Opozorilo: Ti citati niso vedno 100% točni.